Cutia Therapeutics Sustainability Reports

Cutia Therapeutics is a biopharmaceutical company focused on developing innovative and comprehensive treatments for dermatology and skin diseases.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

FIGI: BBG01GVKT2Z0

5 reports from 2023 to 2025

• Cutia Therapeutics 2025 Annual Report
• Cutia Therapeutics 2025 Environmental, Social & Governance Report
• Cutia Therapeutics 2024 Environmental, Social & Governance Report
• Cutia Therapeutics 2023 Annual Report
• Cutia Therapeutics 2023 Environmental, Social & Governance Report